We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$115B
AUM Growth
+$6.24B
Cap. Flow
+$1B
Cap. Flow %
0.87%
Top 10 Hldgs %
23.71%
Holding
4,165
New
247
Increased
1,898
Reduced
1,581
Closed
296

Sector Composition

Rank Sector Weight
1 Technology 14.47%
2 Healthcare 8.69%
3 Financials 8.53%
4 Industrials 6.69%
5 Consumer Discretionary 5.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACN icon
76
Accenture
ACN
$109B
$282M 0.25%
987,309
+104,409
+12% +$28.5M
AMT icon
77
American Tower
AMT
$78.8B
$263M 0.23%
1,286,003
+45,109
+4% +$9.46M
MDLZ icon
78
Mondelez International
MDLZ
$78.5B
$262M 0.23%
3,763,748
+297,084
+9% +$19.7M
DRI icon
79
Darden Restaurants
DRI
$24.9B
$262M 0.23%
1,687,732
+134,935
+9% +$20M
XLY icon
80
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.8B
$259M 0.23%
3,470,130
+346,684
+11% +$24.9M
LLY icon
81
Eli Lilly
LLY
$1.1T
$259M 0.23%
754,371
+66,003
+10% +$22.3M
SPGI icon
82
S&P Global
SPGI
$121B
$258M 0.22%
748,200
+34,821
+5% +$12.3M
BAC icon
83
Bank of America
BAC
$447B
$257M 0.22%
8,988,706
-486,638
-5% -$16.1M
WMB icon
84
Williams Companies
WMB
$87.9B
$253M 0.22%
8,469,970
+398,824
+5% +$12.3M
TMO icon
85
Thermo Fisher Scientific
TMO
$222B
$253M 0.22%
438,761
+11,499
+3% +$6.48M
VPL icon
86
Vanguard FTSE Pacific ETF
VPL
$8.36B
$242M 0.21%
3,561,323
-29,799
-0.8% -$2M
FVD icon
87
First Trust Value Line Dividend Fund
FVD
$8.35B
$241M 0.21%
6,008,200
-510,596
-8% -$20.5M
PM icon
88
Philip Morris
PM
$290B
$236M 0.21%
2,429,044
+147,044
+6% +$14.7M
FISV
89
Fiserv Inc
FISV
$27.8B
$236M 0.21%
2,089,052
-33,362
-2% -$3.67M
T icon
90
AT&T
T
$165B
$234M 0.2%
12,176,173
+649,402
+6% +$12.4M
NVO
91
Novo Nordisk
NVO
$211B
$231M 0.2%
2,905,854
+140,740
+5% +$9.98M
ADP icon
92
Automatic Data Processing
ADP
$109B
$231M 0.2%
1,036,187
-25,893
-2% -$5.84M
HON icon
93
Honeywell
HON
$77B
$229M 0.2%
1,270,271
-9,439
-0.7% -$1.77M
DIS icon
94
Walt Disney
DIS
$178B
$228M 0.2%
2,274,088
+51,130
+2% +$5.15M
FTCS icon
95
First Trust Capital Strength ETF
FTCS
$7.99B
$225M 0.2%
3,088,029
-282,310
-8% -$20.8M
ADBE icon
96
Adobe
ADBE
$109B
$224M 0.19%
582,342
-16,639
-3% -$5.91M
CVS icon
97
CVS Health
CVS
$122B
$223M 0.19%
2,999,148
-242,229
-7% -$20.3M
AMGN icon
98
Amgen
AMGN
$226B
$222M 0.19%
917,399
+112,931
+14% +$27.7M
DE icon
99
Deere & Co
DE
$164B
$221M 0.19%
535,466
-2,560
-0.5% -$1.06M
CCI icon
100
Crown Castle
CCI
$31.3B
$220M 0.19%
1,646,826
+98,787
+6% +$13.7M

Similar funds

Raymond James & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, Raymond James & Associates held 4,165 positions worth $115B, up 5.7% from $109B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q1 2023 filing shows 247 new, 1,898 increased, 1,581 reduced and 296 closed positions. Its largest new stake was VanEck Morningstar International Moat ETF: 787,215 shares worth $25.2M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $551M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q1 2023 buy was VanEck Morningstar International Moat ETF: 787,215 shares worth $25.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q1 2023, an estimated $413M increase.
  • Raymond James & Associates's biggest Q1 2023 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $551M.
  • Raymond James & Associates fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $18.8M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $115B portfolio in Q1 2023.
  • Raymond James & Associates opened 247 new positions and closed 296 in Q1 2023.
  • Raymond James & Associates's portfolio value rose 5.7% quarter-over-quarter to $115B.

Based on Raymond James & Associates's 13F filing for Q1 2023, filed 14 Apr 2023.